Number of Shares
885.00
Current Holdings Value*
$198,130.00
% of Portfolio
5.26%
Total Estimate Gain
$-86,571.35
% of Total Estimate Gain
-29.33%

Amplify Weight Loss Drug & Treatment ETF's West Pharmaceutical Services Inc Holding Summary

As of 2025-03-31, Amplify Weight Loss Drug & Treatment ETF held 885.00 shares of West Pharmaceutical Services Inc(WST), totaling $198,130.00. This investment constitutes 5.26% of their stock portfolio, and Amplify Weight Loss Drug & Treatment ETF now holds 0% of the outstanding West Pharmaceutical Services Inc(WST) stock.

The initial trade took place in 2024Q2. And since then Amplify Weight Loss Drug & Treatment ETF has made 2 purchases of WST, at an average price of $319.11, for a total of 925.00 shares. In addition, there have been 1 sales at an average price of $314.94 for 40.00 shares. Based on historical transaction data and WST's current price of $221.48, Amplify Weight Loss Drug & Treatment ETF's estimated gain on his WST holdings is $-86,571.35, reflecting a -29.33% gain to date.

Amplify Weight Loss Drug & Treatment ETF WST ($221.48) Holding Chart

Amplify Weight Loss Drug & Treatment ETF WST ($221.48) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1